LONDON--(BUSINESS WIRE)--Technavio analysts forecast the global immune checkpoint inhibitors market to grow at a CAGR of more than 19% during the forecast period, according to their latest market ...
NEW YORK, Sept. 26, 2019 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immuno-oncology biopharmaceutical company focused on the acquisition, ...
Survey of the immunogenomic landscape of solid tumors through clinical DNA and RNA sequencing. This is an ASCO Meeting Abstract from the 2019 ASCO-SITC Clinical Immuno-Oncology Symposium. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback